Yale Department of Neurology

08/26/2026

Clinical Chief of Neurodegenerative Disorders and Professor of Neurology Sayed (Ausim) Azizi, MD, PhD, and other experts detail the eligibility criteria for receiving blood tests that are approved for early detection of Alzheimer's disease.

“Good candidates are individuals who are identified as having cognitive impairment distinct from normal aging via abnormal cognitive screening.”

08/14/2026

07/31/2026

The relationship between Alzheimer's disease and the formation of plaques of amyloid beta peptides is widely acknowledged and closely studied.

A research team led by Principal Investigator Stephen Strittmatter, MD, PhD, Vincent Coates Professor of Neurology and Professor of Neuroscience, uncovered the atomic structure of the intermediate stage of amyloid beta. This stage may cause the most neurologic damage, and understanding its structure has important implications for delivering more targeted treatments.

A new study uncovers the structure of a toxic form of amyloid beta driving brain damage associated with Alzheimer’s disease.

07/02/2026

Our stroke team participated in the Ga***rd Gauntlet 5K Trail and Obstacle Run on Saturday, June 13, held on the campus of Ga***rd Specialty Healthcare. This event raised funds for the Ga***rd Sport Association, which harnesses adaptive sports to enhance quality of life for people with physical and visual disabilities.

Photo Credit: Yale Stroke team

06/18/2026

In a recent Q&A, Assistant Professor of Neurology Rebecca Blumenreich, MD, MPH, details common risk factors for , the best methods for prevention, and recent advances in stroke recovery .

In a Q&A, Yale neurologist Rebecca Blumenreich explains the common risk factors for stroke, how new technologies are making it easier to track them — and how people can reduce these risks.

06/01/2026

Recently, Women’s Health Research at Yale Collaborative Member Dr. Carolyn Fredericks was interviewed by Pharmacy Times about the ways the menopausal transition can affect neurological risk in women. In fact:

🧠 MRI and PET studies show women in their 40s and 50s experience changes in brain connectivity – especially memory circuits – linked to declining estrogen during menopause.
🧠 Many neurological disorders change significantly in menopause – from to and even multiple sclerosis ( ) and ’s.
🧠 ’s disease, which constitutes the majority of the research efforts of both Dr. Fredericks and The Fredericks Lab, seems to be significantly influenced by menopause – timing, disease progression, and more.

More investment and continued investigation has the potential to inform treatment, disease management, and even prevention.

📰 Read or watch the interview here: https://www.pharmacytimes.com/view/aan-2026-from-migraines-to-alzheimer-how-the-menopausal-transition-affects-neurological-risk-in-women.

This interview was in conjunction with 2026 AAN, the annual meeting of the American Academy of Neurology.

School of Medicine

05/18/2026

Join us in congratulating Pooja Khatri, MD, MSc, Albert E. Kent Professor & Chair of Neurology and neurologist-in-chief of Yale New Haven Health, on her election to membership in the Association of American Physicians! This recognition honors Khatri as an outstanding leader in care and .

Pooja Khatri, MD, MSc, has been elected to membership in the Association of American Physicians for 2026.

05/05/2026

The Aligning Science Across Parkinson's (ASAP) initiative awarded Neurology Resident M. Elizabeth Deerhake, MD, PhD, with the inaugural ASAP Collaborative Research Network (CRN) Discovery Fellowship! This grant will help advance Deerhake's research identifying genetic drivers of neuroinflammation in Parkinson's disease, with co-mentorship from David Hafler, MD, and Clemens Scherzer, MD.

04/21/2026

A new technique developed at YSM improves molecular profiling of cells by simultaneously comparing and RNA levels across individual types in living tissues.

The new technique, described in Nature Communications, offers a clearer picture of what causes cells to falter in brain diseases.

Learn more: https://bit.ly/4tyeQPx